StonvexLoading…
StonvexStonvexStonvexCore line items from RYN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $483.04M | $986.44M | $786.96M | $907.79M |
Operating Income | $83.34M | $364.11M | $184.70M | $165.82M |
Net Income | $474.38M | $359.15M | $173.49M | $107.08M |
EPS (Diluted) | $3.03 | $2.39 | $1.17 | $0.73 |
Total Assets | $3.40B | $3.47B | $3.65B | $3.79B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $842.94M | $303.06M | $207.70M | $114.25M |
Free Cash Flow OCF − CapEx | Not available | $159.06M | $202.87M | $194.38M |
Shares Outstanding | 161.43M | 148.54M | 148.30M | 147.28M |